Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by MSD .
Filed returns
38
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | MSD | Economic Development and Industry | Government policy event relating to Ireland's life sciences sector (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2026 | MSD | EU Affairs | Ireland’s EU Council Presidency (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Health | Engagement on Life Sciences and Innovation Policy (Public policy or programme) | 9 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Health | Cancer dashboard Ireland (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2025 | MSD | Health | Implementing an Early Access Scheme in Ireland (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2025 | MSD | Health | Ireland’s Cervical Cancer Elimination Plan (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2025 | MSD | Health | Healthcare Innovation (Public policy or programme) | 8 | On lobbying.ie |
| Sep–Dec 2024 | MSD | Health | Health Policy Development for New Programme for Government (Public policy or programme) | 46 | On lobbying.ie |
| May–Aug 2024 | MSD | Health | Meeting with officials from the Department of Health as part of a delegation from the US Chamber of Commerce, to discuss industry wide concerns in Ireland regarding the impact of some aspects of the EU Commission’s… (Legislation) | 1 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | New medicines funding in Budget 2024 (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | New medicines funding in Budget 2024 (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | New medicines Funding in Budget 2024 (Public policy or programme) | 6 | On lobbying.ie |
| May–Aug 2023 | MSD | Health | Vaccination programmes (Matters involving public funds) | 3 | On lobbying.ie |
| May–Aug 2023 | MSD | Health | Access to innovative cancer medicines (Public policy or programme) | 7 | On lobbying.ie |
| May–Aug 2022 | MSD | Health | Access to Medicines (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2021 | MSD | Health | Oncology Policy (Public policy or programme) | 9 | On lobbying.ie |
| Sep–Dec 2020 | MSD | Health | Policy Priorities in a post-pandemic COVID-19 era (Public policy or programme) | 26 | On lobbying.ie |
| Sep–Dec 2020 | MSD | Health | Oncology Policy (Public policy or programme) | 34 | On lobbying.ie |
| May–Aug 2020 | MSD | Health | Oncology Policy (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2019 | MSD | Economic Development and Industry | Development of the Pharmaceutical industry in Ireland (Public policy or programme) | 42 | On lobbying.ie |
| Jan–Apr 2019 | MSD | Communications | Online Healthcare Information (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2018 | MSD | Health | Lung Cancer Policy (Public policy or programme) | 54 | On lobbying.ie |
| May–Aug 2018 | MSD | Health | Coordination on Oncology Medicines (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2018 | MSD | Health | Access to Medicines (Public policy or programme) | 6 | On lobbying.ie |
| Jan–Apr 2018 | MSD | Health | Access to Innovation in Oncology (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2018 | MSD | Health | Immunisation Programmes (Public policy or programme) | 5 | On lobbying.ie |
| Sep–Dec 2017 | MSD | Health | Access to innovation in Oncology (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2017 | MSD | Health | Immunisation Programmes (Public policy or programme) | 7 | On lobbying.ie |
| May–Aug 2017 | MSD | Economic Development and Industry | Support for Foreign Direct Investment in Ireland by MSD (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2017 | MSD | Health | Oncology Policy (Public policy or programme) | 19 | On lobbying.ie |
| May–Aug 2017 | MSD | Health | Immunisation Programmes (Public policy or programme) | 19 | On lobbying.ie |
| Jan–Apr 2017 | MSD | Health | Reimbursement and early access to medicines (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2017 | MSD | Health | Biologic Medicine Legislation (Legislation) | 2 | On lobbying.ie |
| Jan–Apr 2017 | MSD | Economic Development and Industry | Continued support for MSD's presence in Ireland (Public policy or programme) | 7 | On lobbying.ie |
| Jan–Apr 2017 | MSD | Health | Immunisation Policy (Public policy or programme) | 18 | On lobbying.ie |
| Sep–Dec 2016 | MSD | Health | Immunisation Programmes (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2016 | MSD | Health | Future Healthcare Policy (Public policy or programme) | 25 | On lobbying.ie |
| May–Aug 2016 | MSD | Health | The reimbursement of new oncology medicines (Public policy or programme) | 5 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 32 | 84.2% | |
| Economic Development and Industry | 4 | 10.5% | |
| Communications | 1 | 2.6% | |
| EU Affairs | 1 | 2.6% |